Olea europaea leaf
- Generic Name
- Olea europaea leaf
- Drug Type
- Biotech
- Unique Ingredient Identifier
- MJ95C3OH47
Effect of Metformin and Combination of Olive Oil Plus Nutritional Supplements on Inflammatory Markers IL-6 and IL-8 in PCOS.
Phase 2
Completed
- Conditions
- PCO
- Interventions
- First Posted Date
- 2023-07-19
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- Khyber Medical University Peshawar
- Target Recruit Count
- 88
- Registration Number
- NCT05952349
- Locations
- 🇵🇰
Gynecology and Obstetric, Hayatabad Medical Complex, Peshawar, Khyber Pakhtunkhwa, Pakistan
Use of Topical Olive Oil Cream for Prophylaxis Against Acute Radiodermatitis in Breast Cancer Patients
Phase 4
Completed
- Conditions
- Radiodermatitis; Acute
- Interventions
- First Posted Date
- 2022-03-18
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- Cairo University
- Target Recruit Count
- 132
- Registration Number
- NCT05285943
- Locations
- 🇪🇬
Ain Shams University Hospitals, Cairo, Egypt
Effectiveness of Olive Oil Local Application in Orthodontic Patients.
- First Posted Date
- 2021-09-10
- Last Posted Date
- 2021-09-10
- Lead Sponsor
- Minia University
- Target Recruit Count
- 110
- Registration Number
- NCT05040620
- Locations
- 🇪🇬
Ahmed Nasef, Minya, Egypt
Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults
Phase 2
Recruiting
- Conditions
- Cardiovascular Disease
- Interventions
- Drug: palmitoleate-rich oil (PLO)
- First Posted Date
- 2017-12-14
- Last Posted Date
- 2025-05-20
- Target Recruit Count
- 110
- Registration Number
- NCT03372733
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Effect of Ozone Gel on Treatment of Chronic Periodontitis
Phase 2
Completed
- Conditions
- Periodontal Diseases
- Interventions
- First Posted Date
- 2014-02-19
- Last Posted Date
- 2014-02-20
- Lead Sponsor
- October 6 University
- Target Recruit Count
- 40
- Registration Number
- NCT02066337
- Locations
- 🇪🇬
October 6 University, Cairo, Egypt
[E]PANOVA Combined With a [S]TATIN in [P]ATIENTS With HYPERT[R]IGLYCER[I]DEMIA to Reduce Non-HDL CHOLES[T]EROL
Phase 3
Completed
- Conditions
- HypertriglyceridemiaCardiovascular Disease
- Interventions
- First Posted Date
- 2011-08-03
- Last Posted Date
- 2014-12-05
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 646
- Registration Number
- NCT01408303
Olive Oil With Omega 3 to Treat Stasis Dermatitis
Phase 1
- Conditions
- Dermatitis
- First Posted Date
- 2007-01-11
- Last Posted Date
- 2007-01-11
- Lead Sponsor
- Assaf-Harofeh Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT00421161
- Locations
- 🇮🇱
Clinic of Vascular Surgery, Zerifin, Israel
🇮🇱Assaf Harofe MC, Zerifin, Beer Yaacov, Israel
🇮🇱Clinic of vascular surgery, Assaf Harofe MC, Zerifin, Israel
OMEGA-Study: Effect of Omega 3-Fatty Acids on the Reduction of Sudden Cardiac Death After Myocardial Infarction
Phase 3
Completed
- Conditions
- Myocardial Infarction
- Interventions
- Drug: Zodin (drug)
- First Posted Date
- 2005-11-09
- Last Posted Date
- 2008-09-12
- Lead Sponsor
- Stiftung Institut fuer Herzinfarktforschung
- Target Recruit Count
- 3800
- Registration Number
- NCT00251134
- Locations
- 🇩🇪
Elisabeth-Krankenhaus, Recklinghausen, Germany
🇩🇪Klinikum Neustadt, Neustadt/Aisch, Germany
🇩🇪Johanniter-Krankenhaus Rheinhausen, Duisburg, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath